R&D&I

At Biotech NeuroProb, our R&D engine translates cutting-edge discoveries in the gut-brain axis into clinical-grade innovations designed to revolutionize mental and neurological health. By integrating advanced molecular biology with systemic neuroscience, we identify novel therapeutic targets that bridge the gap between laboratory science and transformative patient care. Beyond treating neurological disorders, our research pipeline is dedicated to developing high-impact solutions for the cosmetics industry and human performance optimization. We ensure that every breakthrough, whether a medical therapy or a performance enhancer, is backed by robust data and engineered for scalable global applications. 

Special strains with nanotechnology 

Clinical Trials

At Biotech NeuroProb, innovation is indissociable from rigorous scientific validation. Our commitment to executing clinical trials of excellence is absolute, operating under the strictest ethical and technical standards of Good Clinical Practice (GCP) to ensure total data integrity and participant safety. Beyond mitigating symptoms, our methodology focuses on proving tangible improvements in patients' Quality of Life (QoL), delivering robust evidence that builds lasting trust with clinicians, strategic partners, and global regulatory bodies in the transformative potential of our technologies.

Biotech in Arlington - TEXAS

Patents

At Biotech NeuroProb, our Intellectual Property (IP) strategy is the primary engine of our B2B business model and the structural foundation of our long-term value. We proactively secure and manage a robust patent portfolio that safeguards our unique discoveries in gut-brain axis science, ensuring exclusive competitive advantages for our partners. By transforming complex biological insights into protected assets, we provide the legal and commercial certainty required to de-risk investments and drive the large-scale deployment of next-generation neurological therapies.

Department of Research

Psycobiotics with nanotechnology 

We advance psychobiotics to modulate the gut-brain axis, developing evidence-based solutions that enhance mental health, aesthetic wellness, and human performance through microbiome science.

Plant Tissue Culture

We advance in vitro plant tissue culture to optimize the production of bioactive compounds, ensuring a sustainable and standardized supply of raw materials for healthcare, cosmetics, and human performance solutions.

Human performance optimization

We advance human performance optimization by leveraging the gut-brain axis, developing evidence-based interventions that enhance cognitive clarity, physical resilience, and neurological efficiency through advanced microbiome science.